Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent ...

Results from a phase III clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent ...

Gensco Laboratories LLC d/b/a Gensco Pharma, (Gensco or the Company) a leader in specialty pharmaceuticals, proudly announces ...

Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published ...

Ubrogepant, approved for acute treatment of migraine, may also reduce nonheadache symptoms that occur in the hours preceding ...

A 22-year-old Bolton man’s death was the result of a “gross failure to provide basic medical care” an inquest has concluded.

Discover how dropless cataract surgery enhances patient comfort and outcomes, reducing the need for eye drops and improving ...

A new innovative eye surgery is changing the way ophthalmologists treat patients with severe corneal conditions, without the ...

A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event.